Abbott Laboratories (ABT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
Sales | 9,978,000 | 9,747,000 | 10,091,000 | 10,410,000 | 11,257,000 |
Cost of Goods | 4,483,000 | 4,331,000 | 4,593,000 | 4,629,000 | 4,933,000 |
Gross Profit | 5,495,000 | 5,416,000 | 5,498,000 | 5,781,000 | 6,324,000 |
Operating Expenses | 3,953,000 | 3,907,000 | 4,194,000 | 4,011,000 | 3,948,000 |
Operating Income | 1,542,000 | 1,509,000 | 1,304,000 | 1,770,000 | 2,376,000 |
Interest Expense | 159,000 | 153,000 | 154,000 | 141,000 | 132,000 |
Other Income | 253,000 | 206,000 | 170,000 | 129,000 | 108,000 |
Pre-tax Income | 1,636,000 | 1,562,000 | 1,320,000 | 1,758,000 | 2,352,000 |
Income Tax | 261,000 | 244,000 | 287,000 | 323,000 | 334,000 |
Net Income Continuous | 1,375,000 | 1,318,000 | 1,033,000 | 1,435,000 | 2,018,000 |
Net Income | $1,375,000 | $1,318,000 | $1,033,000 | $1,435,000 | $2,018,000 |
EPS Basic Total Ops | 0.79 | 0.75 | 0.59 | 0.82 | 1.15 |
EPS Basic Continuous Ops | 0.79 | 0.76 | 0.60 | 0.82 | 1.15 |
EPS Diluted Total Ops | 0.78 | 0.75 | 0.59 | 0.81 | 1.14 |
EPS Diluted Continuous Ops | 0.79 | 0.75 | 0.59 | 0.81 | 1.14 |
EPS Diluted Before Non-Recurring Items | 1.08 | 1.03 | 1.03 | 1.15 | N/A |
EBITDA(a) | $2,342,000 | $2,315,000 | $2,111,000 | $2,585,000 | $3,198,000 |